ALK
ALK, or anaplastic lymphoma kinase: a gene that tells your body how to make proteins that help cells talk to each other.
-
OCT 10, 2019 10:30 AM PDTC.E. CREDITS
OCT 10, 2019 10:30 AM PDTAccumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...Speaker: Sven Bocklandt, PhDPresented at: Cancer Research & Oncology 2019Sponsored By: Bionano GenomicsNOV 09, 2017 1:30 PM PST
NOV 09, 2017 1:30 PM PSTThe GeneStrat® Genomic Test is a blood-based series of ddPCR tests for DNA (EGFR, KRAS, BRAF) and multiplexed assays for RNA variants (EML4-ALK, ROS1, RET). In this report we will u...Speaker: Hestia Mellert, PhDPresented at: Clinical Diagnostics & Research 2017MAY 24, 2017 12:00 PM PDT
MAY 24, 2017 12:00 PM PDTR&D in life science, material science, and chemistry is burdened by fragmented and unstructured data (“spreadsheet hell”), and ambiguous or unrecorded methodological data. Thi...Speaker: Tim GardnerPresented at: Lab Automation 2017SEP 09, 2015 9:00 AM PDT
SEP 09, 2015 9:00 AM PDTDATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...JUN 10, 2015 2:00 PM PDT
JUN 10, 2015 2:00 PM PDTMatching the mutational profile of a patient's tumor with appropriate targeted agents is a goal of personalized medicine in oncology. The number of FDA-approved targeted therapies, as well as...Speaker: Stephen Lyle, MD, PhDPresented at: Cardinal Health labXchangeSEP 16, 2014 10:00 AM PDT
SEP 16, 2014 10:00 AM PDTPatients with chromosomal rearrangements resulting in fusion proteins are among the most responsive to published targeted therapy. For example, targeting of the EML4-ALK fusion in non-small c...Speaker: Sean Eddy, PhDSEP 16, 2014 9:30 AM PDT
SEP 16, 2014 9:30 AM PDTLate-stage drug attrition rates in oncology remain higher than in other therapeutic areas. To reduce attrition, it is critical to identify appropriate drug targets and pre-clinical models. Th...Speaker: Nickolay Khazanov, PhDOCT 16, 2013 2:00 PM PDTC.E. CREDITS
OCT 16, 2013 2:00 PM PDTNon Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...Speaker: Roberto Chiarle, MDPresented at: Cancer: Research, Discovery and Therapeutics 2013
OCT 10, 2019
10:30 AM PDT
C.E. CREDITS
OCT 10, 2019
10:30 AM PDT
Accumulation of structural variations (SVs) across the genome is a known trigger factor for oncogenesis. Structural mutations have been clearly implicated in a number of cancers, most notably...
Speaker:
Sven Bocklandt, PhD
Presented at: Cancer Research & Oncology 2019Sponsored By: Bionano Genomics
NOV 09, 2017
1:30 PM PST
NOV 09, 2017
1:30 PM PST
The GeneStrat® Genomic Test is a blood-based series of ddPCR tests for DNA (EGFR, KRAS, BRAF) and multiplexed assays for RNA variants (EML4-ALK, ROS1, RET). In this report we will u...
Speaker:
Hestia Mellert, PhD
Presented at: Clinical Diagnostics & Research 2017
MAY 24, 2017
12:00 PM PDT
MAY 24, 2017
12:00 PM PDT
R&D in life science, material science, and chemistry is burdened by fragmented and unstructured data (“spreadsheet hell”), and ambiguous or unrecorded methodological data. Thi...
Speaker:
Tim Gardner
Presented at: Lab Automation 2017
SEP 09, 2015
9:00 AM PDT
SEP 09, 2015
9:00 AM PDT
DATE: September 9, 2015TIME: 9:00am PDT, 12:00PM EDTDriver mutations are causally implicated in tumorigenesis and disease progression, and they are defined by molecular abnormalities such as ...
JUN 10, 2015
2:00 PM PDT
JUN 10, 2015
2:00 PM PDT
Matching the mutational profile of a patient's tumor with appropriate targeted agents is a goal of personalized medicine in oncology. The number of FDA-approved targeted therapies, as well as...
Speaker:
Stephen Lyle, MD, PhD
Presented at: Cardinal Health labXchange
SEP 16, 2014
10:00 AM PDT
SEP 16, 2014
10:00 AM PDT
Patients with chromosomal rearrangements resulting in fusion proteins are among the most responsive to published targeted therapy. For example, targeting of the EML4-ALK fusion in non-small c...
Speaker:
Sean Eddy, PhD
SEP 16, 2014
9:30 AM PDT
SEP 16, 2014
9:30 AM PDT
Late-stage drug attrition rates in oncology remain higher than in other therapeutic areas. To reduce attrition, it is critical to identify appropriate drug targets and pre-clinical models. Th...
Speaker:
Nickolay Khazanov, PhD
OCT 16, 2013
2:00 PM PDT
C.E. CREDITS
OCT 16, 2013
2:00 PM PDT
Non Small Cell Lung Cancer (NSCLC) is one of the most significant causes of cancer-related mortality worldwide. In about 6-7% of NSCLC, rearrangements involving the Anaplastic Lymphoma Kinase...
Speaker:
Roberto Chiarle, MD
Presented at: Cancer: Research, Discovery and Therapeutics 2013
- Flavonoids
- Medical Marijuana
- Plant Breeding
- Plant Metabolomics
- Fertility
- Breeding
- Cultivation
- Medical Cannabis
- Alkaloid
- Cannabinoid Research
- Polymers & Microfluidics
- Agricultural Biology
- ALS
- CAR T-Cells
- Ultrasound
- Nerve
- CO2
- Immunotherapy
- Cell
- Health
- Drug Development
- Brain
- Alternative Energy
- Plant
- Water
- Plant Sciences
- Agricultural Plant Sciences
- Plant Biology
- Soil Science
- Politics
- Hemp Fiber
- Cannabis
- Research and Development
- Personality
- Lymphoma
- Disease
- Tumor
- Therapy
- T-Cells
- Lung Cancer
- Engineering
- Agricultural Sciences
- Chemotherapy
- Medical Genetics
- Cancer
- Animal Research
- Medical Device
- Animal Production
- Materials Engineering
- Clinical Medicine
- Genetic Engineering
- Stem Cells
- Research
- Science Education
- Stem Cell Research
- Medical Technology
- Education
- Publishing
- Gene
- Data Science
- Wellness
- University
- Angiogenesis
- Bone Marrow
- Tumor Angiogenesis
- Spine
- Protein
- History
- Animals
- Economics
- Diagnosis
- Clinical Evaluation
- Lungs
- Treatment of Cancer
- Cell Therapy
- Clinical Genetics
- Cancer Treatment
- Cancer Cell
- Environmental Chemistry
- Immunity
- Immune System
- Biomass
- Drug Design
- Personalized Medicine
- Plant Genetics
- Political Science
- Botany
- Cannabis Sciences
- Ecology
- Agricultural Economics
- Atmospheric Sciences
- Biofuels
- CRO
- Climate Change
- Metabolomics
- Phytochemistry
- Water Quality
- Tumor Targeting
- Targeted Therapy
- Bones
- Cancer Metabolism
- Aging Population
- Prostate Cancer
- Bone Diseases
- Bone Development
- Systematics
- Clinical Trials
- Cancer Therapeutics
- Therapeutics
- Genome Editing
- Human Genetics
- Surface Characterization
- Animal Models
- Environment
- FDA
- Case Study
- Kinase
- Computational Mechanics
- Functional Medicine
- Pharmaceutical Testing
- Exome Sequencing
- Drug Resistance
- Innovation
- T Cell
- Protein Characterization
- Gene Therapy
- Clinical Lab
- Molecular Genetics
- Sequencing
- Genetic Testing
- Animal Sciences
- Industrial
- Medical Devices
- Data Quality
- Environmental Science
- Science
- Process Chemistry
- Biology
- Long non-coding RNAs
- Platelet
- Liquid Biopsies
- Arthritis
- Anxiety
- Cell Harvesting
- Neuroblastoma